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Abstract
Background: Rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation
(ROHHAD) is a rare disease with a high mortality rate. Although nocturnal hypoventilation (NH) is central to ROHHAD, the
evolution of sleep disordered breathing (SDB) is not well studied. The aim of the study was to assess early manifestations
of SDB and their evolution in ROHHAD syndrome.
Methods: Retrospective study of children with ROHHAD at two Canadian centers. All children with suspected ROHHAD
at presentation underwent polysomnography (PSG) to screen for nocturnal hypoventilation. PSG findings at baseline and
follow-up were collected. Interventions and diagnostic test results were recorded.
Results: Six children were included. The median age of rapid onset obesity and nocturnal hypoventilation (NH) was 3.5
and 7.2 years respectively. On initial screening for ROHHAD 4/6 (66.7 %) children had obstructive sleep apnea (OSA), 1/6
(16.7 %) had NH and 1/6 (16.7 %) had both OSA and NH. Follow up PSGs were performed in 5/6 children as one child
died following a cardiorespiratory arrest. All children at follow up had NH and required non-invasive positive pressure
ventilation. Additionally, 3/6 (50 %) children demonstrated irregular breathing patterns during wakefulness.
Conclusions: Children with ROHHAD may initially present with OSA and only develop NH later as well as dysregulation
of breathing during wakefulness. The recognition of the spectrum of respiratory abnormalities at presentation and over
time may be important in raising the index of suspicion of ROHHAD. Early recognition and targeted therapeutic
interventions may limit morbidity and mortality associated with ROHHAD.
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Background
Rapid-onset obesity with hypothalamic dysfunction, hy-
poventilation and autonomic dysregulation (ROHHAD)
is a rare, heterogeneous syndrome and responsible for
hypothalamic obesity. So far more than 75 cases have
been reported since 1965 when it was first described in
the literature. No specific diagnostic test has been estab-
lished yet, and the natural history of the condition re-
mains poorly understood [1]. The most common early
symptom reported in ROHHAD is excessive weight gain
(20–30 pounds over 6–12 months) in a young child begin-
ning at the age of 2–3 years [2, 3]. Additional features of
ROHHAD include neuroendocrine tumor, hyperprolacti-
nemia, central hypothyroidism, disordered water balance,
failed growth hormone stimulation test, temperature
dysregulation and hypotension. However, given the lack of
standardized definitions and diagnostic tests as well as
epidemiological studies of ROHHAD, the evolution and
spectrum of abnormalities is unclear [2, 3]. Nonetheless, a
high burden of morbidity, as well as mortality rates
between 50 to 60 % necessitates early diagnosis and
subsequent management of ROHHAD, which may lead to
a decrease in morbidity and mortality [2, 3].
Previous published case reports and reviews have des-
cribed obstructive sleep apnea (OSA), central sleep apnea
(CSA) and abnormal ventilatory responses to carbon di-
oxide (CO2) co-existing with nocturnal hypoventilation
(NH). Specific data on sleep disordered breathing (SDB)
at presentation and its evolution in children with sus-
pected ROHHAD are limited [3–7]. As SDB in children
with ROHHAD may predispose to later cardiorespiratory
arrest, studying the evolution of SDB in ROHHAD may* Correspondence: indra.narang@sickkids.ca1Hospital For Sick Children, Toronto, Ontario, Canada
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be crucial for the early recognition and targeted treat-
ments in ROHHAD.
We hypothesized that children with ROHHAD may not
always present with NH at an early stage of ‘ROHHAD
disease’ and NH may evolve over time. The aim of this
case series was to review the baseline and follow up poly-
somnograms in children with suspected ROHHAD and to
describe the evolution of their SDB over time.
Methods
We conducted a retrospective case series review in chil-
dren with ROHHAD at two pediatric institutions across
Canada (The Hospital for Sick Children, Toronto and
the Children’s Hospital of Eastern Ontario, Ottawa). All
sleep history data and PSG findings were accessible through
the sleep charts and physician’s reports. We reviewed all
demographic data, age at onset of obesity, symptoms at
presentation and age at onset of nocturnal hypoventilation
(NH). All symptoms related to hypothalamic and auto-
nomic dysfunction were also recorded.
Additional information such as diagnostic tests and
blood parameters were also obtained. We included all
children diagnosed with ROHHAD between 0 and 18 years
of age. The criteria for the diagnosis of ROHHAD which
is described in its acronym, include rapid onset obesity,
hypothalamic dysfunction, nocturnal hypoventilation and
autonomic dysregulation. The absence of PHOX2B muta-
tion helps to rule out Congenital Central Hypoventilation
Syndrome [2–4]. For the purpose of this study, the above
mentioned defintion of ROHHAD was adapted and
defined if the following 7 criteria were met: 1. history
of rapid onset obesity, 2. hypothalamic dysfunction, 3.
autonomic dysregulation, 4. sleep breathing disorders
(including nocturnal hypoventilation and/or obstructive
sleep apnea and/or central apnea as defined by a formal
overnight PSG described below), 5. a negative test for
PHOX2b mutation, 6. a normal brain MRI scan and 7. the
absence of any genetic mutation that may account for
obesity, autonomic or hypothalamic dysfunction.
Polysomnography
Children with suspected ROHHAD were sent to our
sleep clinic for a PSG to confirm the diagnosis by the
presence of NH. Hence, all our initial PSG were done
when the clinical diagnosis was still uncertain. All chil-
dren underwent standard overnight PSG using a Natus
Sleepworks system (Natus Medical Incorporated, San
Carlos, California, United States) according to standard
international guidelines [8].
PSG measurements included electroencephalogram,
electro-oculogram, submental and bilateral anterior ti-
bialis electromyogram. Respiratory measurements included
chest wall and abdominal belts; nasal air pressure trans-
ducer and/or oronasal thermal sensor, oxygen saturation,
end-tidal and/or trans-cutaneous carbon dioxide monitors.
Video and audio recording as well as body position were
recorded.
Sleep architecture was assessed by standard techniques.
PSG recordings were made according to the standards of
American Academy of Sleep Medicine (AASM) [8]. Re-
corded respiratory data included counts and indices of the
following events: obstructive apnea, central apnea, hypop-
nea and mixed apneas in non-rapid eye movement (NREM)
sleep, REM sleep and total sleep. All respiratory events
were scored according to the AASM scoring guidelines by
a registered polysomnographic technician [8]. OSA severity
was graded according to OAHI, the number of obstructive
apneas, obstructive hypopneas and mixed apneas per hour
during sleep. OAHI of < 1.5 was considered normal, OAHI
from ≥ 1.5 to < 5 was mild OSA; OAHI from ≥ 5 to < 10
was moderate OSA and OAHI ≥ 10 was considered severe
OSA. The central apnea index (CAI) was defined as the
number of central apneas per hour during sleep. A CAI ≥ 5
per hour was considered significant. The mean and nadir
nocturnal oxygen saturation (SaO2) was recorded for
each patient from the overnight PSG as well as the
mean and peak nocturnal CO2. Definition of nocturnal
hypoventilation (AH) was used in accordance to AASM
2007 as a CO2 > 50 mmHg for more than 25 % of the
total sleep time (TST). Specific management or inter-
vention including adenoidectomy, tonsillectomy, and
initiation of non-invasive positive pressure ventilation
(NIPPV) such as continuous positive airway pressure
(CPAP) or Bi-level PAP (Bi-level) following the PSG
findings were also recorded.
In addition, three of six children underwent daytime
cardiorespiratory monitoring to evaluate daytime cardio-
pulmonary physiology. Specifically, this involved con-
tinuous measurements of heart rate, respiratory rate,
oxygen saturations, transcutaneous CO2, respiratory and
abdominal excursions using chest wall and abdominal
belts as well as the use of a nasal airflow channel. This was
undertaken in the sleep laboratory setting while seated up-
right and awake in a chair for the entire duration. The
subject was allowed to read or watch television during this
time. None of the patients fell asleep during this moni-
toring period. Given that there are no defined criteria
for scoring central pauses while awake, central pauses
were scored in accordance to AASM. A central apnea
was recorded if they met the following criteria: the
event lasts 20 s or longer or it lasts at least the duration
of two breaths, is associated with a 3 % or greater oxy-
gen desaturation [8]. No EEG data was applied during
wakefulness.
Statistical analyses
The Statistical Package for Social Sciences software (SPSS
20.0) was used for the calculations of all the parameters.
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Baseline characteristics (sex, onset age of obesity, onset
age of nocturnal hypoventilation, weight and BMI) and
sleep study variables were evaluated by calculating the
proportions, median and range.
Results
We retrospectively identified six children with ROHHAD.
All demographic data are summarized in Table 1. PSG
findings at baseline and follow up are listed in Table 2.
The majority of children (83.3 %) presented with rapid
weight gain during early childhood, while one child pre-
sented later at 9.5 years of age. The sequence of SDB phe-
notypes of each patient is shown in Fig. 1. NH which is
reported to be a cardinal feature of ROHHAD, was diag-
nosed at a median age of 7.2 years. Additional features at
presentation in children being evaluated for suspected
ROHHAD syndrome included hypothalamic dysfunction,
adipsia, diaphoresis, heat intolerance, behavioral problems
and cardiorespiratory arrest.
At baseline 2/6 (33.3 %) children demonstrated NH, 4/6
(66.7 %) children had OSA ranging from mild to severe.
The highest CO2 parameter was 86 mmHg and the lowest
SaO2 was 67 % recorded in a 5 year old female with severe
OSA co-existing with NH. Management following the
baseline PSG consisted of the following: three children
with mild OSA were encouraged to lose weight as the pri-
mary treatment, two children were started on Bi-Level
PAP and one patient with severe OSA underwent an ade-
notonsillectomy as the first line of treatment.
Follow up PSGs were performed in 5/6 children as
one child died prior to a repeat PSG. Follow up PSG
were performed typically 1 year after Bi-level PAP initi-
ation. Patient #3 who had severe OSA and underwent
adenotonsillectomy showed NH 6 months after the first
PSG. In contrast three patients (#1, # 2 and #6) who did
not have NH in their first PSG required between 3 and 7
PSGs (conducted between biannually and yearly) until
we documented NH. In addition, four children had evi-
dence of NH only after repeat PSGs were performed.
These four children had previously documented mild to
severe OSA (Table 2).
Daytime cardiorespiratory monitoring
Due to the cardiorespiratory arrest in one of our patients
and evidence for of daytime oxygen desaturations during
wakefulness, 3/6 (50 %) children underwent daytime car-
diorespiratory monitoring. We were unable to perform
this daytime monitoring in one patient who died and the
remaining patients refused the testing due to parental
work commitments. Cardiorespiratory variables during
wakefulness are summarized in Table 3. All of these
three children had central pauses while awake (see ex-
ample in Fig. 2), durations of which ranged between of
10–47 s. There were mild to moderate oxygen desatura-
tions (lowest recorded oxygen saturation while awake
was 40 %) with a desaturation index between 7.5/h and
35/h. One of these three children (child #1) was diag-
nosed with pulmonary hypertension after. All three chil-
dren were commenced on daytime oxygen therapy to
keep their oxygen saturation above 94 %. No patient re-
quired NIPPV during wakefulness. In addition, child #3
had decreases in heart rate to 40/min during daytime
monitoring (Fig. 3) but did not have persistent bradycardia
of less than 40 beats per minute. Despite severe desatura-
tions while awake in child #3 as well as significant OSA
associated with nocturnal hypoventilation, the child and
his family refused a tracheostomy and ventilation strategy.
Although the main aim of our study was to assess
early manifestation and to document the evolution of
SDB in children with suspected ROHHAD, other fea-
tures of ROHHAD syndrome are shown in Table 4.
Discussion
ROHHAD is a rare and fatal disease with a mortality
rate of up to 50 to 60 % due to cardiorespiratory arrest.
The diagnosis of ROHHAD can be extremely challen-
ging as there is no single confirmatory diagnostic test,
but the early recognition and intervention of this syn-
drome may minimize mortality [2, 9]. This study focused
on SDB in children with ROHHAD syndrome, to ascer-
tain how many children had NH at presentation, given that
NH is defined as a cardinal feature of ROHHAD. This is
important as excluding a diagnosis of ROHHAD of due to
a lack of evidence of NH may result in catastrophic
consequences.
In our study, only 2/6 patients had NH with it at base-
line in our series. OSA was the most common SDB at
presentation. Even though OSA has been documented in
ROHHAD syndrome it’s not included in the diagnostic
criteria. However, in our study, OSA was the initial pres-
entation in regards of SDB. There was evidence of NH
in all our patients but only over time. Moreover, we
found that of the children studied, there was evidence
for abnormal control of breathing during wakefulness
with central pauses in breathing and associated oxygen
desaturations.
Table 1 Demographic Data of patients with ROHHAD syndrome
Characteristics Results
n = 6
Male, number (%) 1 (16.7)
Age of onset of obesity (years) 3.5 (1.5–9.5)
Age of onset of nocturnal hypoventilation (years) 7.2 (5.3–14.7)
BMI at baseline PSG (kg/m2) 32.1 (26.5–40.7)
All values are median (range) unless stated otherwise
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Rapid onset obesity, a major presenting feature of
ROHHAD syndrome was documented in all our chil-
dren at a median age of 3.5 years, with one child pre-
senting beyond 9 years of age, similar to other reported
studies [2, 3, 7, 10]. The median age of onset of NH in
our study was 7.2 years (range 5.3–14.7 years). In the
largest case series thus far, Ize Ludlow and colleagues [2]
report on the respiratory manifestations of 15 ROHHAD
patients. All 15 patients had evidence for NH and 8/15
(53 %) had co-existent OSA and 4/15 (27 %) had cyanotic
episodes. However, whether NH was present at diagnosis
or evolved over time was not described. Alarmingly 9/15
Table 2 Baseline and follow up PSG data in children with suspected ROHHAD











Treatment • Time interval
(years)








1 35.7 4.7 Mild OSA 79 41–47 Weight loss • 1y 4 m 43.5 Severe OSA
and NH
50–54 • Bi-Level PAP
• OAHI 3/h
• CAI 0/h









• 3 • OAHI 9/h
• CAI 0/h
3 26.5 10.1 Severe OSA 83 29–38 • Adenotonsillectomy
• Weight loss
• 6 m 26.6 Severe OSA
and NH
40–53 • Bi-Level PAP
• OAHI 49/h
• CAI 0/h








• 1 • OAHI 0/h
• CAI 0/h
5 40.8 5.3 Severe OSA
and NH







6 39.9 10.0 Mild OSA 81 38–44 Weight loss • 4y 8 m 47.6 Severe OSA
and NH
Peak 51 Bi-Level PAP
• OAHI 4/h
• CAI 0/h
• 8 • OAHI 18/h
• CAI 0/h
Time Interval describes the time between the first and follow-up PSG in the table; Number of PSG refers to the total number of PSG that were performed between
the first PSG and the follow-up PSG in the table; # - patient number 4 was not hypercapnic on follow-up PSG as this was undertaken on Bi-Level PAP
Abbreviations: OSA obstructive sleep apnea, NH nocturnal hypoventilation, OAHI obstructive apnea hypopnea index, CAI central apnea index,
AT adenotonsillectomy
Fig. 1 Sequence of Sleep Disordered Breathing Phenotype in each patient. Abbreviations: OSA Obstructive Sleep Apnea, NH Nocturnal Hypoventilation,
† Patient died. Age of presentation for SDB is shown on the x-axis for each patient
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(60 %) patients were reported to have had a cardiores-
piratory arrest, much higher than in the current study
(1/6, 17 %). Similarly in another case series of 13 patients
with suspected ROHHAD, all 13 patients were reported as
having NH and it is unclear if they had other pre-existing
sleep related respiratory disorders [4].
The aforementioned case series and additional case re-
ports offer a great deal of insight into the respiratory
manifestations of ROHHAD syndrome [2, 5, 10–12].
Although NH is a definitive criteria of ROHHAD, chil-
dren who fit all diagnostic criteria except NH in an over-
night PSG need vigilant follow up with serial PSGs as
NH may develop over time. As such, it is important to
recognize that other sleep disorders may be associated
with ROHHAD prior to catastrophic respiratory events.
Additional findings in our study showed evidence for
hypoxemia during wakefulness, characterized in our study
to be related to central pauses which may be an indicator
of worse respiratory morbidity. Indeed, blunted chemo-
sensory responses such as abnormal respiratory response
to hypercapnia has been previously described in children
with ROHHAD which may account for our observations
[6]. These observations may be critically important in the
context that other authors have suggested that early inter-
vention with nocturnal artificial ventilation may improve
daytime ventilation [13].
In our study 2/6 (33.3 %) patients were diagnosed with
AH and treated with nocturnal Bi-level ventilation after
the initial PSG. However, prior to a follow up PSG, one
patient died following a cardiorespiratory arrest. The















1 9.4 100 24 37–52 260 35 73
2 14.3 97 29 35–48 270 7.5 93
3 11.2 69 21 38–49 358 25.6 62
Daytime cardiorespiratory monitoring was performed while patients were sitting and watching tv. All patients who underwent the test showed abnormal control
of breathing during wakefulness
Abbreviation: tcCo2 transcutaneous CO2
Fig. 2 Cardiorespiratory monitoring during wakefulness (patient #3). Ten year old male with abnormal control of breathing during wakefulness.
The test was performed while the child was sitting and watching tv. This was a 90 s recording during wakefulness which shows several central
pauses (black arrow) with associated mild to moderate oxygen desaturations (red arrow). The desaturations were transient with recovery to baseline
Reppucci et al. Orphanet Journal of Rare Diseases  (2016) 11:106 Page 5 of 8
remaining 5/6 patients all required Bi-Level ventilation
with 2/6 requiring supplemental oxygen during the day.
In contrast to other studies, no patient required either
invasive nor full time ventilatory support [2, 4, 5]. How-
ever, a child with significant daytime ventilatory abnor-
malities not controlled with oxygen therapy coupled with
NH would likely require a tracheostomy and invasive ven-
tilation but no patient in our series fit this criteria. Serial
PSGs and repeated daytime monitoring will be necessary
to ensure these patients are stable with their current venti-
latory support. Interestingly, in a recent review of 51 cases
of ROHHAD syndrome, 69 % required artificial ventila-
tion via tracheostomy with 31 % requiring 24 h support
which concur with data from other published case series
[5]. The high incidence of invasive ventilation among
those ROHHAD patients compared with our study may
be related to more severe phenotype of ROHHAD associ-
ated with significant NH at a young age (mean age of inva-
sive ventilation was 3.8 years). Furthermore, differences in
clinical practice and use of Bi-level ventilation versus ven-
tilation via a tracheostomy between countries could ac-
count for some of the variations observed in the mode of
ventilation. Similar to the other published data, cardiores-
piratory arrest is a manifestation of ROHHAD and one
child in our study died from a sudden event [2–4].
The strength of our study was the inclusion of children
with baseline PSGs before they were diagnosed with
Fig. 3 Oxygen saturations and heart rate during wakefulness (patient #3). Ten year old male with mild to severe oxygen desaturations and heart
rate variability while awake. Desaturations to lowest SaO2 of 60 % and bradycardia of 40 beats per minute were recorded. These events were
transient and returned to baseline without any need of intervention


















Tumor of neural crest origin 1
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ROHHAD syndrome’. The limitations of our study in-
clude the retrospective design, lack of standardization
with regards to timing of follow up PSG monitoring
and the lack of a control group of similarly obese children
to compare effects of a change in BMI that may have con-
tributed to associated obesity-associated hypoventilation.
Given the rarity of this condition, an additional, substan-
tial limitation of our study, is the small number of patients
included. Further, the daytime physiological monitoring
could be performed only in 3/6 patients as 1 died and 2
were refused by the parents. Finally, we did not have pul-
monary function tests on our patients to further explain
abnormal gas exchange observed nocturnally. A larger
multi centered study with children suspected of having
ROHHAD is needed to confirm the findings of our study.
In summary, we have shown that children with sus-
pected ROHHAD syndrome may not have NH at presen-
tation but may only have evidence of mild OSA on their
PSG. The absence of NH at presentation does not exclude
ROHHAD, as NH may develop over time and thus only
be evident with serial PSGs. Furthermore, we found evi-
dence of abnormal breathing patterns during wakefulness
with associated hypoxemia. Based on these findings, the
authors would advocate for close and serial monitoring
with PSGs of all children with suspected ROHHAD in-
cluding daytime monitoring of cardiopulmonary variables
once NH is evident. Importantly, the recognition of the
spectrum of respiratory abnormalities associated with sus-
pected ROHHAD syndrome at presentation and over time
may be important in raising the index of suspicion for
ROHHAD condition, and predispose to targeted interven-
tions to limit associated morbidity and mortality.
Conclusions
Children with suspected ROHHAD syndrome with no evi-
dence of nocturnal hypoventilation on polysomnogram
should be monitored closely by serial polysomnograms. A
missed or delayed diagnosis of ROHHAD syndrome can
lead to fatal consequences such as cardiorespiratory arrest.
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